Inventor
Ute Jaeger
Inventor
Munich, DE
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes21%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C12NMicroorganisms or enzymes10%
C12YEnzymes7%
PatentTitleYear
10,865,237Nucleic acids encoding anti-Factor P antibodies202010,184,005Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD3820199,988,440Compositions comprising antibodies targeting factor P20189,758,590'Anti-CD38 human antibodies and uses thereof'20179,200,061'Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i'20159,051,365'Antibodies that bind factor P'20158,715,657'Therapeutic antibodies binding IL12Rβ1'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to NOVARTIS AG (4)· patent assignee history
2014–2015Patents assigned to JAEGER UTE (2)· patent assignee history
2014Patents assigned to BARDROFF MICHAEL (1)· patent assignee history
2014Patents assigned to CARBALLIDO HERRERA JOSE M (1)· patent assignee history
2014–2020Based in Munich, DE· patent location history
2017–2019Patents assigned to MORPHOSYS AG (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 4 | 2014–2020 |
| JAEGER UTEself | 2 | 2014–2015 |
| MORPHOSYS AG | 2 | 2017–2019 |
| BARDROFF MICHAEL | 1 | 2014 |
| CARBALLIDO HERRERA JOSE M | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Munich, DE | 7 | 2014–2020 |